Technical Analysis for MCRB - Seres Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 6.57 -0.15% -0.01
MCRB closed down 0.15 percent on Monday, March 18, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical MCRB trend table...

Date Alert Name Type % Chg
Mar 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 18 Calm After Storm Range Contraction 0.00%
Mar 18 Wide Bands Range Expansion 0.00%
Mar 18 Down 3 Days in a Row Weakness 0.00%
Mar 15 Calm After Storm Range Contraction -0.15%
Mar 15 Narrow Range Bar Range Contraction -0.15%
Mar 15 NR7 Range Contraction -0.15%
Mar 15 Upper Bollinger Band Walk Strength -0.15%
Mar 15 Wide Bands Range Expansion -0.15%
Mar 14 New Uptrend Bullish -1.35%

Older signals for MCRB ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Seres Therapeutics, Inc., a microbiome therapeutics platform company, focuses on the development of biological drugs designed to restore health by repairing the function of a dysbiotic microbiome. Its lead product candidate is SER-109, a bacterial spore ecology, which has completed open label Phase Ib/2 clinical study for the prevention of further recurrences of Clostridium difficile infection (CDI). The company's product candidates in pre-clinical development comprise SER-262, an Ecobiotic microbiome therapeutic designed to be used following antibiotic treatment of primary CDI to prevent the initial recurrence of CDI; SER-287 to treat inflammatory bowel disease, including ulcerative colitis; and SER-155 to treat enteric pathogens, such as antibiotic-resistant bacteria. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Medicine Medical Specialties Autoimmune Diseases Inflammatory Bowel Disease Ulcerative Colitis Diarrhea Antimicrobial Resistance Digestive Diseases Clostridioides Difficile Clostridium Difficile Infection
Is MCRB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.75
52 Week Low 4.42
Average Volume 385,011
200-Day Moving Average 7.2705
50-Day Moving Average 6.0474
20-Day Moving Average 6.163
10-Day Moving Average 6.302
Average True Range 0.6173
ADX 29.7
+DI 39.0246
-DI 14.6937
Chandelier Exit (Long, 3 ATRs ) 6.538100000000001
Chandelier Exit (Short, 3 ATRs ) 6.8519
Upper Bollinger Band 7.1171
Lower Bollinger Band 5.2089
Percent B (%b) 0.71
BandWidth 30.962194
MACD Line 0.162
MACD Signal Line 0.0855
MACD Histogram 0.0765
Fundamentals Value
Market Cap 266.16 Million
Num Shares 40.5 Million
EPS -2.42
Price-to-Earnings (P/E) Ratio -2.71
Price-to-Sales 17.96
Price-to-Book 4.50
PEG Ratio 0.03
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.34
Resistance 3 (R3) 7.33 7.06 7.21
Resistance 2 (R2) 7.06 6.87 7.07 7.16
Resistance 1 (R1) 6.82 6.75 6.69 6.83 7.12
Pivot Point 6.55 6.55 6.49 6.56 6.55
Support 1 (S1) 6.31 6.36 6.18 6.32 6.02
Support 2 (S2) 6.04 6.24 6.05 5.98
Support 3 (S3) 5.80 6.04 5.93
Support 4 (S4) 5.81